Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This observational study is following people with depression, psychosis, or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with depression or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with bipolarity or bipolarity Type 1. Taking part may give some people access to Glucose, but direct benefit is not guaranteed.
This study is looking at whether iTAB-CV can help people with bipolarity, Non-Adherence, Medication, Hypertension, or depression. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with severe mental illness to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is looking at how a digital support tool works for people with bipolarity, Major Depressive Episode, Primary Care, or Major Depression in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Active iTBS with Sham stimulation for people with depression or Depression in bipolarity. Participants receive Active iTBS or Sham stimulation and complete study visits and assessments.
This observational study is looking at how a digital support tool works for people with bipolarity in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram), can help people with Treatment Resistant Schizophrenia or Treatment Resistant bipolarity. Participants take part in Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram), and complete follow-up assessments.
This observational study is following people with depression, anxiety, or psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with depression, Suicidal Behavior, or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing Clonidine with placebo for people with depression, Catatonia, bipolarity, or Delirium Postseizure. Participants receive Clonidine or placebo and complete study visits and assessments.
This study is comparing mHealer with Enhanced Usual Care for people with Psychosis, Mania, or Depression. Participants receive mHealer or Enhanced Usual Care and complete study visits and assessments.
This observational study is following people with depression, bipolarity, or Mild Cognitive Impairment to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether questionnaires and follow-up can help people with Multimorbidity, Depression - depression, Bipolar, or Integrated Care. Participants receive integrated care intervention tailored to the needs of older adults leaving at home with mood disorders and multimorbidity in Leuven or usual care and complete study visits and assessments.
This study is looking at whether Northern Light Technology (SADelite lamp) bright light-therapy can help people with Bipolar Type II Disorder or Depression, Bipolar. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Treatment-Resistant Depression or Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at be conducted at the NIH Clinical Center in Bethesda, MD for people with depression or bipolarity. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with Depression, Treatment Resistant Depression, bipolarity, or Mental Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD) for people with depression or bipolarity. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing Xenon with placebo for people with depression or Depression in bipolarity. Participants receive Xenon or placebo and complete study visits and assessments.
This observational study is following people with Schizophrenia, bipolarity, or depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing BXCL501 80 Micrograms with placebo for people with psychosis or bipolarity. Participants receive BXCL501 80 Micrograms or placebo and complete study visits and assessments.
This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.